Kyle Carver, CFO of Evommune EVMN, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $415.1K. The latest trade was on 05/28.

KC

KC

Kyle Carver

CFO

Company

Evommune EVMN

First filing

25/12/11

Trades

8 trades

Buys / sales

0 / 1

12-month net buying

−$415.1K

Last trade

05/28

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
EvommuneEVMN	Open-market sale10b5-1 plan	05/28	06/01	18,175 sh	$22.84	$415,117	−23.4%